# Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)

> **NCT06292585** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 194 (estimated)

## Conditions studied

- EpiDural Hematoma
- Traumatic Brain Injury

## Interventions

- **PROCEDURE:** MMA embolization plus medical therapy
- **DRUG:** Medical therapy alone

## Key facts

- **NCT ID:** NCT06292585
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-02
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06292585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06292585, "Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06292585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*